Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.9074
Delayed Data
As of 3:59pm ET
 +0.014 / +1.57%
Today’s Change
0.26
Today|||52-Week Range
2.40
-31.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues4.0M4.3M4.7M5.4M
 
 
 
 
 
Cost of Goods Sold442.1K487.7K494.6K546.5K
 
 
 
 
 
Depreciation And Amortization132.2K140.1K149.6K117.8K
 
 
 
 
 
 
Operating ExpensesGross Income3.4M3.7M4.1M4.7M
 
 
 
 
 
General Expenses7.7M6.3M6.6M5.3M
 
 
 
 
 
Research And Development3.9M2.6M2.7M2.5M
 
 
 
 
 
Total Operating Expenses8.3M6.9M7.3M6.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-2.6M-2.6M-580.0K
 
 
 
 
 
Extraordinary Credit0.001.1M1.1M1.5M
 
 
 
 
Extraordinary Charge-1.6M0.000.000.00
 
 
Pre-Tax Equity Earnings-26.8K-10.0K-12.2K-2.9K
 
 
 
 
 
Interest Expense On Debt2.1M2.2M2.2M7.5M
 
 
 
 
 
Other Expenses4.4K708.00-37.3K-39.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-3.7M-3.7M-6.7M
 
 
 
 
 
Income Taxes0.00-436.1K0.000.00
 
 
Minority Interest-340.00-174.00-241.00-116.00
 
 
 
 
 
Discontinued Operations0.00758.6K0.000.00
 
 
Net Income-8.1M-2.5M-3.7M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS150.2M154.6M155.3M155.4M
 
 
 
 
 
Shares To Calculate EPS Diluted150.2M154.6M155.3M155.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.02-$0.02-$0.04
 
 
 
 
 
EPS Diluted-$0.05-$0.02-$0.02-$0.04